247 related articles for article (PubMed ID: 33767995)
21. Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
Li W; Gao LN; Song PP; You CG
Aging (Albany NY); 2020 Feb; 12(4):3558-3573. PubMed ID: 32087603
[TBL] [Abstract][Full Text] [Related]
22. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
23. Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
Luo B; Lin J; Cai W; Wang M
Front Genet; 2021; 12():771847. PubMed ID: 34938319
[TBL] [Abstract][Full Text] [Related]
24. Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
Zhou L; Wu Y; Xin L; Zhou Q; Li S; Yuan Y; Wang J; Wu D
Am J Transl Res; 2020; 12(10):6775-6792. PubMed ID: 33194072
[TBL] [Abstract][Full Text] [Related]
25. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
Liu L; Liang L; Mai G; Chen Y
FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
[TBL] [Abstract][Full Text] [Related]
26. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
Front Genet; 2021; 12():768930. PubMed ID: 34733320
[No Abstract] [Full Text] [Related]
27. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
28. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
Front Genet; 2020; 11():568192. PubMed ID: 33133154
[TBL] [Abstract][Full Text] [Related]
29. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
31. A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma.
Wang W; Xu C; Ren Y; Wang S; Liao C; Fu X; Hu H
Stem Cells Int; 2021; 2021():7036059. PubMed ID: 34691191
[TBL] [Abstract][Full Text] [Related]
32. Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.
He Y; Zeng S; Hu S; Zhang F; Shan N
Front Genet; 2020; 11():584624. PubMed ID: 33193718
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
[TBL] [Abstract][Full Text] [Related]
34. Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma.
Liu X; Xiao C; Tan F; Yi R; Zhao X
Transl Cancer Res; 2020 Oct; 9(10):6275-6286. PubMed ID: 35117237
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma.
Tang D; Huang W; Yang Z; Wu X; Sang X; Wang K; Cao G
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22852. PubMed ID: 34396630
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Related Gene-Based Signature Can Evaluate the Tumor Immune Microenvironment and Predict the Prognosis of Colon Adenocarcinoma Patients.
He X; Ding J; Cheng X; Xiong M
Int J Gen Med; 2021; 14():9853-9862. PubMed ID: 34938106
[TBL] [Abstract][Full Text] [Related]
37. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
Luo HY; Tang WL; Xiang L; Peng LL; Wu DB; Zhu ZY; Gu HT; Tang YH; Perkins RS; Shen HY; Wang YX
J Gastrointest Oncol; 2022 Dec; 13(6):3025-3037. PubMed ID: 36636093
[TBL] [Abstract][Full Text] [Related]
39. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma.
Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
Front Genet; 2020; 11():617872. PubMed ID: 33488680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
